找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Drug Discovery and Development; From Targets and Mol Ramarao Poduri Book 2021 Springer Nature Singapore Pte Ltd. 2021 Drug discovery.Pharma

[復制鏈接]
樓主: Covenant
31#
發(fā)表于 2025-3-27 00:32:49 | 只看該作者
32#
發(fā)表于 2025-3-27 01:43:07 | 只看該作者
https://doi.org/10.1007/978-3-7091-8827-9n research and development of stem cells, selecting the source for stem cells, various feasible applications of stem cells, pharmacological bridging with stem cells, preclinical safety evaluation of stem cells, and finally a section on potential applications of stem cells in future.
33#
發(fā)表于 2025-3-27 05:49:49 | 只看該作者
Negative und komplexe Zahlen, Polynome,horough knowledge of the toxicological potential of nanocarriers. Further, the harmonious integration of academia, researcher, industries and regulatory bodies is warranted to ensure the proper regulation of their use.
34#
發(fā)表于 2025-3-27 10:29:33 | 只看該作者
Genetics and Drug Discovery,iew about the mechanisms involved and aim for new drug candidates. Here in this chapter, we discuss the overview of the basic principles involved in genetics, genetic mutations, and related methods engaged in drug discovery.
35#
發(fā)表于 2025-3-27 15:56:09 | 只看該作者
Discovery and Development of Stem Cells for Therapeutic Applications,n research and development of stem cells, selecting the source for stem cells, various feasible applications of stem cells, pharmacological bridging with stem cells, preclinical safety evaluation of stem cells, and finally a section on potential applications of stem cells in future.
36#
發(fā)表于 2025-3-27 20:16:37 | 只看該作者
37#
發(fā)表于 2025-3-27 21:58:16 | 只看該作者
38#
發(fā)表于 2025-3-28 04:00:29 | 只看該作者
39#
發(fā)表于 2025-3-28 06:32:21 | 只看該作者
Clinical Research in Pharmaceutical Drug Development,g proper endpoints, selecting correct study designs, securing quality data, and statistical analyses..As clinical research encompasses a large?part of?drug development, it is difficult to cover?the subject in detail in one chapter; hence we are providing a high-level?overview.
40#
發(fā)表于 2025-3-28 12:49:55 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-14 19:52
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復 返回頂部 返回列表
崇左市| 嘉荫县| 兰溪市| 尼勒克县| 化德县| 逊克县| 西丰县| 西华县| 淄博市| 班戈县| 开平市| 苏尼特右旗| 桓仁| 和田县| 桐乡市| 崇文区| 华安县| 富蕴县| 延庆县| 南召县| 呈贡县| 浦东新区| 恩施市| 西畴县| 容城县| 松阳县| 临沭县| 洪雅县| 手机| 乐都县| 江陵县| 河间市| 锡林浩特市| 特克斯县| 阜康市| 石泉县| 和田市| 龙川县| 衡山县| 诸暨市| 洛川县|